2026 Sheryl S. Moy: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	56	4498	4132	2036	1839	138	12300

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Neuroscience

4498

4132

2036

1839

138

12300

Overview

Sheryl S. Moy is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research spans multiple areas within biochemistry, genetics, molecular biology, and neuroscience, with a particular focus on genetics and neurodevelopmental disorders as well as neuroscience and neuropharmacology.

Their main fields of study include:

Biochemistry, Genetics and Molecular Biology
Neuroscience

Within these fields, their work covers a variety of subfields, notably:

Molecular Biology
Genetics
Cognitive Neuroscience
Cellular and Molecular Neuroscience
Neurology

The core topics addressed in their publications reflect areas of ongoing scientific investigation:

Genetics and Neurodevelopmental Disorders
Autism Spectrum Disorder Research
Neuroscience and Neuropharmacology Research
Neuroinflammation and Neurodegeneration Mechanisms
Neuroendocrine regulation and behavior
Tryptophan and brain disorders
Sleep and Wakefulness Research

Sheryl S. Moy has frequently collaborated with several researchers, including:

Viktoriya D. Nikolova
Kathryn M. Harper
Natallia V. Riddick
Todd J. Cohen
Jeremy M. Simon

Their publications commonly appear in these venues:

UNC Libraries
bioRxiv (Cold Spring Harbor Laboratory)
Molecular Autism
Neurobiology of Stress
Scientific Reports

Among notable papers authored or co-authored by Sheryl S. Moy are:

"Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research," 2020, Genetics
"Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome," 2021, Nature Genetics
"An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline," 2020, Nature Communications
"MicroRNA-29 is an essential regulator of brain maturation through regulation of CH methylation," 2021, Cell Reports
"Beyond the looking glass: recent advances in understanding the impact of environmental exposures on neuropsychiatric disease," 2020, Neuropsychopharmacology

Best Publications

Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice

Sheryl S Moy;J. J. Nadler;A. Perez;R. P. Barbaro

1616
Citations
Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors.

Georgia M. Alexander;Sarah C. Rogan;Atheir I. Abbas;Blaine N. Armbruster

1101
Citations
Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains

Sheryl S. Moy;Jessica J. Nadler;Nancy B. Young;Antonio Perez

891
Citations
Automated apparatus for quantitation of social approach behaviors in mice.

J. J. Nadler;S. S. Moy;G. Dold;D. Trang

842
Citations
Social Approach and Repetitive Behavior in Eleven Inbred Mouse Strains

Sheryl S. Moy;Jessica J. Nadler;Nancy B. Young;Randal J. Nonneman

328
Citations
Social approach in genetically engineered mouse lines relevant to autism.

S. S. Moy;J. J. Nadler;N. B. Young;R. J. Nonneman

328
Citations
Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65

Xi Ping Huang;Joel Karpiak;Wesley K. Kroeze;Hu Zhu

286
Citations
Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.

Gary E Duncan;Sheryl S Moy;Antonio Perez;Dawn M Eddy

280
Citations
Social approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments.

Jacqueline N. Crawley;Thomas Chen;Amit Puri;Richard Washburn

271
Citations
Development of a mouse test for repetitive, restricted behaviors: relevance to autism.

Sheryl S. Moy;Jessica J. Nadler;Michele D. Poe;Randal J. Nonneman

221
Citations
Mouse models of autism spectrum disorders: the challenge for behavioral genetics.

Sheryl S. Moy;Jessica J. Nadler;Terry R. Magnuson;Jacqueline N. Crawley;Jacqueline N. Crawley

192
Citations
Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

Gary E Duncan;Sheryl S Moy;Darin J Knapp;Robert A Mueller

191
Citations
SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats.

Darin J. Knapp;David H. Overstreet;Sheryl S. Moy;George R. Breese

187
Citations
Chemogenetic inactivation of ventral hippocampal glutamatergic neurons disrupts consolidation of contextual fear memory

Hu Zhu;Kristen E Pleil;Daniel J Urban;Sheryl S Moy

174
Citations
Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain.

Bryce C. Ryan;Nancy B. Young;Jacqueline N. Crawley;James W. Bodfish

164
Citations
Disruption of maternal parenting circuitry by addictive process: Rewiring of reward and stress systems

Helena J. V. Rutherford;Sarah K. Williams;Sheryl Moy;Linda C. Mayes

163
Citations
Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice.

H Fu;L Kang;J S Jennings;S S Moy

151
Citations
Behavioral deficits in an Angelman syndrome model: effects of genetic background and age.

Hsien Sung Huang;Andrew J. Burns;Randal J. Nonneman;Lorinda K. Baker

148
Citations
A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats

David H. Overstreet;Darin J. Knapp;Sheryl S Moy;George R. Breese

144
Citations
The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles.

George R. Breese;Darin J. Knapp;Hugh E. Criswell;Sheryl S. Moy

140
Citations